Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Revenue (2017 - 2026)

Nutex Health (NUTX) has disclosed Revenue for 17 consecutive years, with $216.5 million as the latest value for Q1 2026.

  • For Q1 2026, Revenue rose 2.22% year-over-year to $216.5 million; the TTM value through Mar 2026 reached $880.0 million, up 40.95%, while the annual FY2025 figure was $875.3 million, 82.36% up from the prior year.
  • Revenue hit $216.5 million in Q1 2026 for Nutex Health, up from $151.7 million in the prior quarter.
  • Across five years, Revenue topped out at $267.8 million in Q3 2025 and bottomed at $28.4 million in Q3 2022.
  • Average Revenue over 5 years is $119.9 million, with a median of $76.1 million recorded in 2024.
  • On a YoY basis, Revenue climbed as much as 3828.19% in 2022 and fell as far as 75.93% in 2022.
  • Nutex Health's Revenue stood at $53.7 million in 2022, then increased by 29.68% to $69.7 million in 2023, then skyrocketed by 269.77% to $257.6 million in 2024, then plummeted by 41.12% to $151.7 million in 2025, then surged by 42.73% to $216.5 million in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $216.5 million, $151.7 million, and $267.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.